Iatrogenic Creutzfeldt–Jakob disease

Atsushi Kobayashi, Tetsuyuki Kitamoto, Hidehiro Mizusawa

Research output: Chapter in Book/Report/Conference proceedingChapter

7 Citations (Scopus)

Abstract

Iatrogenic transmission of Creutzfeldt–Jakob disease (CJD) has occurred through particular medical procedures. Among them, dura mater grafts and pituitary-derived growth hormone obtained from human cadavers undiagnosed as CJD are the most frequent sources of infection. Recent advances in our knowledge about dura mater graft- and human pituitary-derived growth hormone-associated CJD patients have revealed that the combination of the infected CJD strain and the PRNP genotype of the patient determines their clinical, neuropathologic, and biochemical features. In this chapter, we summarize the clinical, neuropathologic, biochemical, and diagnostic features of dura mater graft- and human pituitary-derived growth hormone-associated CJD patients for the appropriate diagnosis of iatrogenic CJD.

Original languageEnglish
Title of host publicationHandbook of Clinical Neurology
PublisherElsevier B.V.
Pages207-218
Number of pages12
DOIs
Publication statusPublished - 2018

Publication series

NameHandbook of Clinical Neurology
Volume153
ISSN (Print)0072-9752
ISSN (Electronic)2212-4152

Keywords

  • Creutzfeldt–Jakob disease
  • M1 strain
  • V2 strain
  • acquired
  • dura mater graft
  • human pituitary-derived growth hormone
  • iatrogenic

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Iatrogenic Creutzfeldt–Jakob disease'. Together they form a unique fingerprint.

  • Cite this

    Kobayashi, A., Kitamoto, T., & Mizusawa, H. (2018). Iatrogenic Creutzfeldt–Jakob disease. In Handbook of Clinical Neurology (pp. 207-218). (Handbook of Clinical Neurology; Vol. 153). Elsevier B.V.. https://doi.org/10.1016/B978-0-444-63945-5.00012-X